Show simple item record

dc.contributor.authorMarincowitz, C
dc.contributor.authorLecky, F
dc.contributor.authorAllgar, Victoria
dc.contributor.authorSheldon, T
dc.date.accessioned2021-08-09T11:22:27Z
dc.date.available2021-08-09T11:22:27Z
dc.date.issued2019-06
dc.identifier.issn2044-6055
dc.identifier.issn2044-6055
dc.identifier.otherARTN e028912
dc.identifier.urihttp://hdl.handle.net/10026.1/17473
dc.description.abstract

<jats:sec><jats:title>Objective</jats:title><jats:p>To evaluate the impact of National Institute for Health and Care Excellence (NICE) head injury guidelines on deaths and hospital admissions caused by traumatic brain injury (TBI).</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>All hospitals in England between 1998 and 2017.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Patients admitted to hospital or who died up to 30 days following hospital admission with International Classification of Diseases (ICD) coding indicating the reason for admission or death was TBI.</jats:p></jats:sec><jats:sec><jats:title>Intervention</jats:title><jats:p>An interrupted time series analysis was conducted with intervention points when each of the three guidelines was introduced. Analysis was stratified by guideline recommendation specific age groups (0–15, 16–64 and 65+).</jats:p></jats:sec><jats:sec><jats:title>Outcome measures</jats:title><jats:p>The monthly population mortality and admission rates for TBI.</jats:p></jats:sec><jats:sec><jats:title>Study design</jats:title><jats:p>An interrupted time series analysis using complete Office of National Statistics cause of death data linked to hospital episode statistics for inpatient admissions in England.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The monthly TBI mortality and admission rates in the 65+ age group increased from 0.5 to 1.5 and 10 to 30 per 100 000 population, respectively. The increasing mortality rate was unaffected by the introduction of any of the guidelines.</jats:p><jats:p>The introduction of the second NICE head injury guideline was associated with a significant reduction in the monthly TBI mortality rate in the 16–64 age group (-0.005; 95% CI: −0.002 to −0.007).</jats:p><jats:p>In the 0–15 age group the TBI mortality rate fell from around 0.05 to 0.01 per 100 000 population and this trend was unaffected by any guideline.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The introduction of NICE head injury guidelines was associated with a reduced admitted TBI mortality rate after specialist care was recommended for severe TBI. The improvement was solely observed in patients aged 16–64 years.</jats:p><jats:p>The cause of the observed increased admission and mortality rates in those 65+ and potential treatments for TBI in this age group require further investigation.</jats:p></jats:sec>

dc.format.extente028912-e028912
dc.format.mediumElectronic
dc.languageen
dc.language.isoeng
dc.publisherBMJ
dc.subjecthead injury
dc.subjecthealth policy
dc.subjecttraumatic brain injury
dc.subjectAdolescent
dc.subjectAge Factors
dc.subjectAged
dc.subjectBrain Injuries, Traumatic
dc.subjectCraniocerebral Trauma
dc.subjectEngland
dc.subjectFemale
dc.subjectHospital Mortality
dc.subjectHumans
dc.subjectInfant, Newborn
dc.subjectInternational Classification of Diseases
dc.subjectInterrupted Time Series Analysis
dc.subjectMale
dc.subjectPatient Admission
dc.subjectPractice Guidelines as Topic
dc.subjectQuality Improvement
dc.subjectRisk Assessment
dc.titleEvaluation of the impact of the NICE head injury guidelines on inpatient mortality from traumatic brain injury: an interrupted time series analysis
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000471197000097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue6
plymouth.volume9
plymouth.publication-statusPublished
plymouth.journalBMJ Open
dc.identifier.doi10.1136/bmjopen-2019-028912
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeEngland
dc.identifier.eissn2044-6055
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1136/bmjopen-2019-028912
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV